Banner

December 3, 2008

Ken Getz At DIA

Tufts Data: Veteran P.I.s Drop Out

In the United States, more seasoned veterans in the clinical investigator world drop out. In rest-of-world, it’s the new P.I.’s who are more likely to leave industry-sponsored research.

Who Should Not Recruit?

Clarification: Pfizer Site Strategy

A clarification to recent ClinPage coverage of Pfizer at DIA.

thumbnail
Ken Getz At DIA

Tufts Data: Veteran P.I.s Drop Out

July 19, 2007

By SuzR

In countries outside the U.S., principal investigators who elect not to do any more trials are usually the nervous newbies. That’s not a shock. What is surprising is that here in the U.S., those leaving clinical research, never to return,…

thumbnail
Who Should Not Recruit?

Clarification: Pfizer Site Strategy

July 11, 2007

By Mark Uehling

After a complaint from Pfizer, we’ve updated a recent story about DIA. There’s a link to our first story at the bottom of this article. It’s clear ClinPage accurately quoted Andy Lee, Pfizer’s vice president of clinical study and data…